Related Experiment Videos
Is schizophrenia linked to alteration in cellular immunity?
B Sperner-Unterweger1, C Barnas, W W Fleischhacker
1Department of Psychiatry, Innsbruck University Clinics, Austria.
Schizophrenia Research
|July 1, 1989
Summary
This study found normal neopterin levels in most schizophrenia patients, but a link between neopterin and symptom severity in chronic cases. Acute patients showed increased neopterin during treatment, suggesting immune system changes in schizophrenia.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Schizophrenia's etiology remains debated, with viral and immunological factors proposed.
- Neopterin serves as a biomarker for cellular immune system activation.
Purpose of the Study:
- To investigate the viral hypothesis of schizophrenia and potential immunological dysfunction.
- To assess neopterin levels in acute and chronic schizophrenia patients.
Main Methods:
- Neopterin levels were measured in acute and chronic schizophrenic patients.
- Correlations were examined between neopterin and psychopathological symptom scores (e.g., BPRS).
- Longitudinal observation of acute patients during treatment was conducted.
Main Results:
- Neopterin levels were within the normal range for both acute and chronic schizophrenia groups.
- A significant correlation was found between neopterin concentrations and BPRS scores in chronic residual schizophrenia.
- Acute patients exhibited lower baseline neopterin levels compared to controls, with a significant increase during the first week of treatment, paralleling symptom improvement.
Conclusions:
- Findings do not strongly support a generalized immune activation in schizophrenia but suggest specific immune alterations.
- The observed changes in neopterin may relate to stress, neurotransmitter synthesis, or treatment effects rather than a direct viral trigger.
- Further research is needed to elucidate the complex interplay between the immune system and schizophrenia pathophysiology.